The cancer diagnostics company has gone into a trading halt following an adverse decision on reimbursement of its US bladder tests.
The medical services provider has lifted profits to a more sustainable level.
Andrew Gray's Potentia Capital has been pursuing take-privates in Australia but no such plan for Vista yet.
Travel software provider given 'underperform' rating as analyst initiates full coverage of stock.
Share price has stabilised after Australian conjecture of a possible bid sparked a buying flurry, following months of bad news.
The Restaurant Brands chair told shareholders they created more confusion than added value.
Listed retirement fund operator will install a new CEO in July, while the group pursues its ‘large format’ village strategy.
Used car dealer’s transformation complete as CEO changeover nears.
The probiotic manufacturer has re-entered the black.
Xero’s free cash flow – cash left over after operating and capital expenses – more than tripled over the past year, beating market expectations by 133%.